搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Chlamydia muridarum 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (ispG), partial CSB-YP868602CIU
CSB-EP868602CIU
CSB-BP868602CIU
CSB-MP868602CIU
CSB-EP868602CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum Methionine--tRNA ligase (metG), partial CSB-YP868603CIU
CSB-EP868603CIU
CSB-BP868603CIU
CSB-MP868603CIU
CSB-EP868603CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum 50S ribosomal protein L19 (rplS) CSB-YP868604CIU
CSB-EP868604CIU
CSB-BP868604CIU
CSB-MP868604CIU
CSB-EP868604CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum Uncharacterized protein TC_0275 (TC_0275) CSB-YP868605CIU
CSB-EP868605CIU
CSB-BP868605CIU
CSB-MP868605CIU
CSB-EP868605CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum Uncharacterized protein TC_0268 (TC_0268), partial CSB-YP868606CIU
CSB-EP868606CIU
CSB-BP868606CIU
CSB-MP868606CIU
CSB-EP868606CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum Probable outer membrane protein pmpE (pmpE), partial CSB-YP868607CIU
CSB-EP868607CIU
CSB-BP868607CIU
CSB-MP868607CIU
CSB-EP868607CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum Methionine aminopeptidase (map) CSB-YP868608CIU
CSB-EP868608CIU
CSB-BP868608CIU
CSB-MP868608CIU
CSB-EP868608CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum UDP-N-acetylenolpyruvoylglucosamine reductase (murB) CSB-YP868609CIU
CSB-EP868609CIU
CSB-BP868609CIU
CSB-MP868609CIU
CSB-EP868609CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] (glmS), partial CSB-YP868610CIU
CSB-EP868610CIU
CSB-BP868610CIU
CSB-MP868610CIU
CSB-EP868610CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum 50S ribosomal protein L25 (rplY) CSB-YP868611CIU
CSB-EP868611CIU
CSB-BP868611CIU
CSB-MP868611CIU
CSB-EP868611CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum 50S ribosomal protein L34 (rpmH) CSB-YP868612CIU
CSB-EP868612CIU
CSB-BP868612CIU
CSB-MP868612CIU
CSB-EP868612CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum Bifunctional enzyme MurC/Ddl (murC/ddl), partial CSB-YP868613CIU
CSB-EP868613CIU
CSB-BP868613CIU
CSB-MP868613CIU
CSB-EP868613CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum UPF0092 membrane protein TC_0117 (TC_0117), partial CSB-YP868614CIU1
CSB-EP868614CIU1
CSB-BP868614CIU1
CSB-MP868614CIU1
CSB-EP868614CIU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum Riboflavin biosynthesis protein RibD (ribD) CSB-YP868615CIU
CSB-EP868615CIU
CSB-BP868615CIU
CSB-MP868615CIU
CSB-EP868615CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum Phosphoenolpyruvate carboxykinase [GTP] (pckG), partial CSB-YP868616CIU
CSB-EP868616CIU
CSB-BP868616CIU
CSB-MP868616CIU
CSB-EP868616CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum Phosphatidylserine decarboxylase proenzyme (psd) CSB-YP868617CIU
CSB-EP868617CIU
CSB-BP868617CIU
CSB-MP868617CIU
CSB-EP868617CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum UPF0111 protein TC_0063 (TC_0063) CSB-YP868618CIU
CSB-EP868618CIU
CSB-BP868618CIU
CSB-MP868618CIU
CSB-EP868618CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia muridarum Glutamyl-tRNA reductase (hemA) CSB-YP868619CIU
CSB-EP868619CIU
CSB-BP868619CIU
CSB-MP868619CIU
CSB-EP868619CIU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. jejuni serotype O:2 Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP868620CZA
CSB-EP868620CZA
CSB-BP868620CZA
CSB-MP868620CZA
CSB-EP868620CZA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter jejuni subsp. jejuni serotype O:2 50S ribosomal protein L3 (rplC) CSB-YP868621CZA
CSB-EP868621CZA
CSB-BP868621CZA
CSB-MP868621CZA
CSB-EP868621CZA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>